Vishnevskiĭ B I, Steklova L N
Probl Tuberk Bolezn Legk. 2008(12):5-8.
Drug resistance of Mycobacterium tuberculosis (MBT) to essential and reserve antituberculous drugs (ATD) was monitored in patients with tuberculosis of respiratory organs (ROT) and at extrapulmonary sites (EPT) in 2005-2007. The standard indirect absolute concentration technique was used to study the drug resistance of 578 MBT strains from pretreated patients with ROT and that of 159 MT strains from those with EPT. With all sites of tuberculosis, a poor trend continues to show an increase in the total frequency of MBT resistance (from 82.3 to 85.2% in ROT and from 43.7 to 59.3% in EPT) and its severer pattern due to MRD (from 69.5 to 78.0% in patients with ROT and from 20.8 to 35.5% in those with EPT). The rate of MTB resistance to 4 ATDs or more is 73.7 and 34.6% in patients with ROT and in those with ERT, respectively. The total resistance of MBT to 7-8 ATDs was revealed in every three patients with ROT (33.0%) and in 12.6% of those with EPT.
2005年至2007年期间,对呼吸器官结核(ROT)患者和肺外部位结核(EPT)患者的结核分枝杆菌(MBT)对一线和二线抗结核药物(ATD)的耐药性进行了监测。采用标准间接绝对浓度技术研究了578株来自ROT初治患者的MBT菌株和159株来自EPT患者的MT菌株的耐药性。在所有结核部位,MBT耐药总频率持续呈不良上升趋势(ROT患者从82.3%升至85.2%,EPT患者从43.7%升至59.3%),且由于多耐药(MRD)导致的耐药模式更为严重(ROT患者从69.5%升至78.0%,EPT患者从20.8%升至35.5%)。ROT患者和ERT患者中,MTB对4种及以上ATD的耐药率分别为73.7%和34.6%。每3例ROT患者(33.0%)和12.6%的EPT患者中发现MBT对7 - 8种ATD的总耐药情况。